Topkara, Veli KVeli KTopkaraChambers, Kari TKari TChambersYang, Kai-ChienKai-ChienYangTzeng, Huei-PingHuei-PingTzengEvans, SarahSarahEvansWeinheimer, CarlaCarlaWeinheimerKovacs, AttilaAttilaKovacsRobbins, JeffreyJeffreyRobbinsBarger, PhilipPhilipBargerMann, Douglas LDouglas LMann2024-07-192024-07-192016-04-07https://scholars.lib.ntu.edu.tw/handle/123456789/719897To elucidate the mechanisms for reverse LV remodeling, we generated a conditional (doxycycline [dox] off) transgenic mouse tetracycline transactivating factor-TRAF2 (tTA-TRAF2) that develops a dilated heart failure (HF) phenotype upon expression of a proinflammatory transgene, TNF receptor-associated factor 2 (TRAF2), and complete normalization of LV structure and function when the transgene is suppressed. tTA-TRAF2 mice developed a significant increase in LV dimension with decreased contractile function, which was completely normalized in the tTA-TRAF2 mice fed dox for 4 weeks (tTA-TRAF2). Normalization of LV structure and function was accompanied by partial normalization (~60%) of gene expression associated with incident HF. Similar findings were observed in patients with dilated cardiomyopathy who underwent reverse LV remodeling following mechanical circulatory support. Persistence of the HF gene program was associated with an exaggerated hypertrophic response and increased mortality in tTA-TRAF2 mice following transaortic constriction (TAC). These effects were no longer observed following TAC in tTA-TRAF2, wherein there was a more complete (88%) reversal of the incident HF genes. These results demonstrate that reverse LV remodeling is associated with improvements in cardiac myocyte biology; however, the persistence of the abnormal HF gene program may be maladaptive following perturbations in hemodynamic loading conditions.enjournal article10.1172/jci.insight.8603827158672